Summit Investment Advisors »

Denali Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $251k 12k 20.52
2023-12-31 $263k 12k 21.46
2023-09-30 $242k 12k 20.63
2023-06-30 $288k 9.8k 29.51
2023-03-31 $201k 8.7k 23.04
2022-12-31 $259k 8.7k 29.70
2022-09-30 $229k 7.5k 30.66
2022-06-30 $219k 7.5k 29.32
2022-03-31 $230k 7.1k 32.24
2021-12-31 $318k 7.1k 44.58
2021-09-30 $360k 7.1k 50.46
2021-06-30 $560k 7.1k 78.50
2021-03-31 $292k 5.1k 57.09
2020-12-31 $441k 5.3k 83.71
2020-09-30 $199k 5.6k 35.82
2020-06-30 $134k 5.6k 24.12
2020-03-31 $73k 4.2k 17.41
2019-12-31 $73k 4.2k 17.41
2019-09-30 $57k 3.7k 15.38
2019-06-30 $77k 3.7k 20.78
2019-03-31 $86k 3.7k 23.21
2018-12-31 $77k 3.7k 20.78
2018-09-30 $81k 3.7k 21.86
2018-06-30 $21k 1.4k 15.42
2018-03-31 $27k 1.4k 19.82